NCT05937308 - NEUROMARK Registry Study | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

June 12, 2023

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions

Chronic Rhinitis

Interventions

DEVICE

NEUROMARK System

The NEUROMARK System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis.

Trial Locations (7)

22310

Metropolitan ENT, Alexandria

33511

Florida ENT & Allergy, Brandon

35242

Alabama Nasal & Sinus Center, Birmingham

75071

ENT & Allergy Texas, McKinney

84403

Ogden Clinic, Ogden

90006

Sensa Health, Los Angeles

95661

Sacramento ENT, Roseville